Cipla Limited
Date of the meeting 19th July 2017 Type of meeting In person Attendees: Investor / Analysts Fund / Firm Reliance Mutual Fund Mr. Ashwani Kumar, Mr. Sailesh Rajbhan and
Download Cipla Limited
Information
Domain:
Source:
Link to this page:
Documents from same domain
PROFILE OF DIRECTORS (1) - Cipla
www.cipla.comPROFILE OF DIRECTORS (1) Dr. Y. K. Hamied, Non-Executive Chairman Dr. Y. K. Hamied is Non-Exec utive Chairman of Cipla, and represents the second generation of Cipla’s founding family.
Cipla EU divests stake in Chase Pharmaceuticals to …
www.cipla.comPress Release Cipla EU divests stake in Chase Pharmaceuticals to Allergan ~ Chase’s lead Alzheimer’s dementia drug CPC-201 successfully completed Phase 2 and is ready for further clinical development
JP Morgan Healthcare Conference - cipla.com
www.cipla.comFY18 FY19 FY20 FY21 FY22E Revenue INR Cr. CAGR 68% FY18-22E INR 500 Cr Annualized business with new partnerships 60+ Trade generic business: Strengthening position, portfolio breadth and connect with channel Robust coverage to tier-2 and below markets Creating delight with digital connect H1FY22 YoY Gr% 41% 36% 76% 53% Integrated web-based
Related documents
indoresez.nic.in
indoresez.nic.in16 gold filaments pvt. ltd 17 safe-flex international limited 18 shakti pumps (india)limited 19 ve commercial vehicles limited 20 cipla limited
Renewed list of WC Certificates - Central Drugs Standard ...
www.cdsco.nic.in1 M/s. Norex Flavours Pvt Ltd. Granted 2 M/s. Natco Pharma Limited, Chemical Division, TS Granted 3 M/s. Nakoda Chemicals Ltd Granted 4 M/s. Mylan Laboratories Ltd Granted
Public Assessment Report - GOV.UK
www.mhra.gov.ukThis is a summary of the Public Assessment Report (PAR) for Ipravent CFC-Free Inhaler 20 micrograms per actuation pressurised inhalation, solution (PL 36390/0083; UK/H/5289/001/DC).
WARFARIN 1 MG, 3 MG AND 5 MG TABLETS - GOV.UK
www.mhra.gov.ukThis is a summary of the public assessment report (PAR) for Warfarin 1 mg, 3 mg and 5 mg Tablets (PL 36390/0136-0138). It explains how Warfarin 1 mg, 3 mg and 5 mg
CAC list updation with email address and contact details.
www.mpcb.gov.in28 19/1/2012 Cosmo Films Ltd. Aurangabad Mr. Janardan Gupta Mr. Navnath More Mr. Prasad Bagde Vive President G.M. Executive-HR janardan.gupta@cosmofilms.com
Cipla EU divests stake in Chase Pharmaceuticals to Allergan
www.cipla.comPress Release Cipla EU divests stake in Chase Pharmaceuticals to Allergan ~ Chase’s lead Alzheimer’s dementia drug CPC-201 successfully completed Phase 2 …
Schedule of Pharmaceutical Benefits - Minfos
www.minfos.com.au2 Schedule of Pharmaceutical Benefits – January 2019 Fees, Patient Contributions and Safety Net Thresholds The following fees, patient contributions and safety net thresholds apply as at 1 January 2019 and are included, where